Kawagishi, Naoki
Suda, Goki
Kimura, Megumi
Maehara, Osamu
Yamada, Ren
Tokuchi, Yoshimasa
Kubo, Akinori
Kitagataya, Takashi
Shigesawa, Taku
Suzuki, Kazuharu
Ohara, Masatsugu
Nakai, Masato
Sho, Takuya
Natsuizaka, Mitsuteru
Morikawa, Kenichi
Ogawa, Koji
Kudo, Yusuke
Nishida, Mutsumi
Sakamoto, Naoya
Funding for this research was provided by:
AMED (JP20fk0210072, JP20fk0210064, JP20fk0210056, JP20fk0310101, JP20fk0210047, JP20fk0210048, JP20fk0210058, JP20fk0210066, JP20fk0210067)
Article History
Received: 8 January 2021
Accepted: 15 April 2021
First Online: 28 April 2021
Competing interests
: Professor Naoya Sakamoto received lecture fees from Bristol Myers Squibb and Pharmaceutical K. K, grants and endowments from MSD K. K and Chugai Pharmaceutical Co., Ltd, and a research grant from Gilead Sciences Inc. Dr. Goki Suda received research grants from Bristol Myers Squibb. The other authors declare no competing interests.